Specific Ion Detection of Aryloxy Beta Blocking Drugs for Metabolic Fate Determinations-Applications to Alprenolol in Rats and Dogs
- 1 January 1978
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Studies on the contribution of active metabolites to the anticonvulsant effects of propranololEuropean Journal of Pharmacology, 1977
- The Concept of Reactive Electrophilic Metabolites in Chemical Carcinogenesis: Recent Results with Aromatic Amines, Safrole, and Aflatoxin B1Published by Springer Nature ,1977
- Quantitative determination of propranolol, propranolol glycol and N-desisopropylpropranolol in brain tissue by electron capture gas chromatographyJournal of Chromatography A, 1976
- Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentographyJournal of Chromatography A, 1975
- GLC Determination of Propranolol, Other β-Blocking Drugs, and Metabolites in Biological Fluids and TissuesJournal of Pharmaceutical Sciences, 1974
- Identification of the major urinary metabolite of alprenolol in man, dog and ratLife Sciences, 1974
- Electron Impact Fragmentation Studies of β-Blocking Drugs and Their Metabolites by GC-Mass SpectroscopyJournal of Pharmaceutical Sciences, 1972
- Pharmacology of 4‐hydroxypropranolol, a metabolite of propranololBritish Journal of Pharmacology, 1971
- Plasma Propranolol Levels in the Quantitative Assessment of -adrenergic Blockade in ManBMJ, 1970
- The Synthesis and Local AnæSthetic Properties of AryloxypropanolaminesJournal of Pharmacy and Pharmacology, 1952